Original Source(s)
Related Content
VA/DoD guideline broadens tobacco treatment
Recommendations prioritize varenicline and combination NRT while extending pharmacotherapy to patients not ready to quit.
September 28, 2026
-
5 min
FDA clears targeted cholangiocarcinoma therapy
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026
-
2 min
ACS report: Lung cancer deaths plunge as survival doubles
Lung cancer deaths fell by more than half among US males as smoking declined, earlier-stage diagnoses increased, and 5-year relative survival doubled.
September 28, 2026
-
6 min
